Pharmacological effects of drug conjugates: is morphine 6-glucuronide an exception?
- 1 January 1992
- journal article
- review article
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 13 (8), 302-304
- https://doi.org/10.1016/0165-6147(92)90095-n
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Glucuronidation and its Role in Regulation of Biological Activity of DrugsAnnual Review of Pharmacology and Toxicology, 1992
- A novel class of enkephalinase inhibitors containing a C-terminal sulfo groupJournal of Medicinal Chemistry, 1992
- O-Methylated and sulfoconjugated catecholamines: differential activities at human platelet α2-adrenoceptorsCanadian Journal of Physiology and Pharmacology, 1991
- Morphine 6-glucuronide and morphine 3-glucuronide as molecular chameleons with unexpected lipophilicityJournal of Medicinal Chemistry, 1991
- Morphine-3-glucuronide - a potent antagonist of morphine analgesiaLife Sciences, 1990
- ANALGESIC ACTIVITY OF MORPHINE-6-GLUCURONIDEThe Lancet, 1988
- Morphine-6-glucuronide: Analgesic effects and receptor binding profile in ratsLife Sciences, 1988
- POTENTIAL ANALGESIC CONTRIBUTION FROM MORPHINE-6-GLUCURONIDE IN CSFThe Lancet, 1987
- Enhanced binding of morphine and nalorphine to opioid delta receptor by glucuronate and sulfate conjugations at the 6-positionLife Sciences, 1987
- Analgesic Potencies of Morphine 3- and 6-Sulfates After Intracerebroventricular Administration in Mice: Relationship to Structural Characteristics Defined by Mass Spectrometry and Nuclear Magnetic ResonanceJournal of Pharmaceutical Sciences, 1985